If your PC is running slowly or has disk errors you need to address the problem. Rather than trying to uninstall programs you could run a scan on your hard drive to fix any errors. Here’s how to do ...

Disc Medicine, Inc. develops novel therapeutics targeting red blood cell biology, focusing on heme biosynthesis and iron homeostasis for the treatment of serious hematologic diseases. The company ...

One of the beneficiaries of the FDA's national priority vouchers, Disc Medicine, has had its marketing application turned down by the regulator. A complete response letter (CRL) was sent by the FDA ...

Disc Medicine’s effort to introduce a new therapy for a rare blood disorder with few treatment options has been derailed with the FDA turning down the application and asking for more data from another ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Adam Feuerstein is a senior ...

FDA rejected accelerated approval because Phase II biomarker reductions (whole-blood metal-free protoporphyrin IX) were not shown to correlate with sunlight exposure–based clinical benefit in the ...

Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...

Sarah Jividen, RN, BSN, is a trained neuro/trauma, and emergency room nurse turned healthcare writer. As a journalism major, she combined her love for writing with her passion for high-level patient ...